479 A lymph-node targeted amphiphile vaccine induces potent cellular and humoral immunity to SARS-CoV-2
Main Authors: | Martin Steinbuck, Peter DeMuth, Lochana Seenappa, Christopher Haqq, Aniela Jakubowski, Lisa McNeil |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Similar Items
-
723 Lymph node-targeted AMP-vaccine enables tumor-directed mKRAS-specific immune responses with potent polyfunctional and cytolytic activity
by: Martin Steinbuck, et al.
Published: (2020-11-01) -
Mistakes in ultrasound diagnosis of superficial lymph nodes
by: Ewa J. Białek, et al.
Published: (2017-03-01) -
Nanoparticulate STING agonists are potent lymph node-targeted vaccine adjuvants
by: Crespo, Monica P., et al.
Published: (2015) -
Neutrophil recruitment to lymph nodes limits local humoral response to Staphylococcus aureus.
by: Olena Kamenyeva, et al.
Published: (2015-04-01) -
Cationic amphiphilic drugs are potent inhibitors of yeast sporulation.
by: Ulrich Schlecht, et al.
Published: (2012-01-01)